San Antonio, TX, United States of America

Kochat Haridas

This inventor holds 28 USPTO granted patents, plus 8 CIPO patents, primarily in Pharmaceutical Formulations. Top assignee: Bionumerik Pharmaceuticals, Inc.. Active years: 1995-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kochat Haridas. Retrieved from https://idiyas.com/inventor/kochat-haridas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 323(Granted Patents)


Location History:

  • Houston, TX (US) (1995 - 1997)
  • San Antonio, TX (US) (1995 - 2001)

Company Filing History:


Years Active: 1995-2001

Loading Chart...
Loading Chart...
Areas of Expertise:
Camptothecin Derivatives
Pharmaceutical Formulations
Dithioethers
Poorly Water Soluble
Lipophilic Compounds
Aqueous Formulations
Toxicity Reduction
Mesna
Sterile Formulations
Platinum Compounds
Lactone Stability
28 patents (USPTO):Explore Patents

Title: **Kochat Haridas: Innovator in Pharmaceutical Patents**

Introduction

Kochat Haridas, based in San Antonio, Texas, is an esteemed inventor with an impressive portfolio of 28 patents. His innovative contributions to the pharmaceutical field have had a significant impact on cancer treatment and toxicity management.

Latest Patents

One of his notable inventions is related to highly lipophilic camptothecin derivatives. This invention introduces novel derivatives of camptothecin, particularly focusing on compounds with substitutions at specific carbon positions (C-7, C-9, C-10, C-11, or C-12). These compounds serve as Topoisomerase I inhibitors, offering promising methods for treating various cancers. Additionally, Haridas has developed pharmaceutical formulations that incorporate these novel compounds in solution or suspension, combined with pharmaceutical excipients.

Another significant patent involves mercaptans and disulfides. This invention details novel compositions that either conclude with a sulfhydryl moiety or exist as disulfides. These compounds could include terminal sulfonate or phosphonate moieties, and they hold numerous applications, such as serving as toxicity-reducing agents when administered alongside various antineoplastic agents.

Career Highlights

Kochat Haridas's career is marked by significant contributions to the field of pharmaceutical sciences, reflecting a dedication to innovation and research. His role at Bionumerik Pharmaceuticals, Inc. has facilitated the advancement of his groundbreaking ideas and has positioned him as a leader in his area of expertise.

Collaborations

Throughout his career, Haridas has collaborated with notable colleagues, including Frederick H Hausheer and Dhanabalan Murali. These professional relationships have fostered a collaborative environment that enhances the research and development activities within the company.

Conclusion

Kochat Haridas stands out as a leading inventor in the pharmaceutical industry. With 28 patents to his name and groundbreaking inventions that address critical issues in cancer treatment and drug toxicity, his work continues to inspire future innovations. His ongoing commitment to research at Bionumerik Pharmaceuticals, Inc. highlights the significant role he plays in advancing health sciences for the betterment of patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…